PDUFA date is early March 2021. I was looking at various opinions as to the likelihood of approval and opinion is pretty divided. My own view based on just enough information and understanding to be dangerous is that they will get a conditional approval. The point that sold me was one neurologist who feels that drug combinations are likely to offer the best outcome for AD but that under the current FDA framework it is difficult to design a combination trial for AD unless one leg of the trail is already an approved drug.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.78 |
Change
-0.040(2.20%) |
Mkt cap ! $302.2M | |||
| Open | High | Low | Value | Volume |
| $1.82 | $1.83 | $1.78 | $205.3K | 113.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1097 | $1.78 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.81 | 9361 | 2 |
View Market Depth
| Last trade - 16.10pm 21/07/2025 (20 minute delay) ? |
| CGS (ASX) Chart |